Drug Trial Radar · NCT01995890
Effect of Nepafenac Eye Drops on Intraocular Pressure in Normal Eyes
Last checked: Nov 20, 2026Latest source record: Nov 27, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
327
Actual
Start
Dec 2012
Primary completion
Feb 2013
Study completion Apr 2013
Sponsor
- Lead sponsor
- Dr T V Patel Eye InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 27, 2013
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Who can join
- All sexes
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The Nevanac product information insert says that it can cause increase in eye pressure in 5-10% of patients. There is very little published literature on the effect of topical Nepafenac eye drops on eye pressure in normal people. The purpose of our study is to report this effect with a working hypothesis that there is no increase in eye pressure following use of Nepafenac eye drops.
Conditions
- Intraocular Pressure
Interventions
nepafenacDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Intraocular pressureTime frame: 4 weeks
- Intraocular pressureTime frame: 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dr TV Patel Eye Insititute
Vadodara, Gujarat, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.